Memo

New poll shows strong support for President Biden’s agenda lowering prescription drug prices and standing up to big drug companies

Economic Security and Corporate Power
May 2, 2024

This week, Navigator Research released new polling on the issue. This memo details the strong support demonstrated by this poll for Medicare drug price negotiation, disapproval of Big Pharma and their congressional allies, and the public’s rejection of Big Pharma’s misinformation and spin.

Memo

MEMO: Opposition to National Monuments motivated by anti-government sentiments

Energy and the Environment
March 19, 2024

On Wednesday the MAGA-led House Natural Resources will hear a bill to curb the creation of new National Monuments through the Antiquities Act. In just the few years of his Presidency, Joe Biden has used this authority to protect iconic historic sites such as the Emmit Till and Mamie Till-Mobley National monument in Mississippi and Illinois and the

Memo

MEMO: Expect Industry-Funded Hostility at Hearings with Consumer Financial Protection Bureau Director Chopra

Economic Security and Corporate Power
November 29, 2023

This week, Consumer Financial Protection Bureau Director Rohit Chopra will deliver his semi-annual report before both the House Financial Services and Senate Banking committees where he is expected to detail the agency’s efforts to lower costs for American consumers by combating corporate price-gouging and junk fees

back to top